Physician profile
Christopher J Desantis
NPI 1306972831
$951.28
in general payments reported to CMS, 2019-2025
12 companies · $37.77 in 2025
The $37.77 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $47.51 · 2021: $167 · 2022: $164 · 2023: $108 · 2024: $58.50 · 2025: $37.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $446.70 | 2019-2023 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $201.76 | 2019-2025 | Bridion |
| Takeda Pharmaceuticals U.S.A., INC. | $91.02 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $41.78 | 2022 | |
| Janssen Biotech, INC. | $40.22 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.10 | 2019 | |
| Intercept Pharmaceuticals, INC. | $23.52 | 2022 | |
| Acacia Pharma INC | $21.76 | 2022 | |
| Qol Medical, LLC | $15.97 | 2021 | |
| Redhill Biopharma INC. | $15.18 | 2021 | |
| Shionogi INC | $14.78 | 2020 | |
| Shire North American Group INC | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Desantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.